Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of antimicrobial resistance
3.2.1.2 Increasing prevalence of infectious diseases
3.2.1.3 Rising awareness and screening programs
3.2.1.4 Advancements in diagnostic technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with the procedures
3.2.2.2 Lack of standardized protocols
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Solution, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Diagnostic kits
5.3 Diagnostic systems
5.4 Diagnostic software
5.5 Services
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Public health surveillance
6.3 Laboratory surveillance
6.4 Clinical diagnostics
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Research & academic institutes
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Accelerate Diagnostics, Inc.
9.3 Becton, Dickinson and Company (BD)
9.4 Biomereiux SA
9.5 Bruker Corporation
9.6 Himedia Laboratories Pvt. Ltd.
9.7 Opgen Inc.
9.8 Danaher Corporation
9.9 Luminex Corporation
9.10 Merck & Co., Inc.
9.11 Thermo Fisher Scientific Inc.
